Skip to Main Content

Author Details

Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
2010
49
22
PMIDPaper TitleJournal TitlePublished Year
36083132Facts and Hopes on the Use of Artificial Intelligence for Predictive Immunotherapy Biomarkers in Cancer.Clin Cancer Res2023
38024636PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma.EJHaem2023
38032021Advanced Diffusion-Weighted MRI for Cancer Microstructure Assessment in Body Imaging, and Its Relationship With Histology.J Magn Reson Imaging2023
37439938MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.Eur Radiol2023
37198249A framework for artificial intelligence in cancer research and precision oncology.NPJ Precis Oncol2023
35103827Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis.Eur Radiol2022
35678860Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task force.Eur Radiol2022
35719569Promoting Handwriting Fluency for Preschool and Elementary-Age Students: Meta-Analysis and Meta-Synthesis of Research From 2000 to 2020.Front Psychol2022
36097219RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF<sup>V600E</sup> metastatic colorectal cancer.Nat Med2022
35954318Radiomic Signatures Associated with CD8<sup>+</sup> Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study.Cancers (Basel)2022
35181943Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology.Magn Reson Med2022
32909055Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis.Eur Radiol2021
33497314A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.Radiology2021
34635786Robust imaging habitat computation using voxel-wise radiomics features.Sci Rep2021
34421754Editorial: Sustainable and Environmentally Concerned Citizens: Garden-Based Learning to Promote the Importance of Physical, Natural, and Social Resources.Front Psychol2021
33436737Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma.Sci Rep2021
32568634Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors.J Clin Oncol2020
31757877Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria.Clin Cancer Res2020
31874108Genomics of lethal prostate cancer at diagnosis and castration resistance.J Clin Invest2020
33120239Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer.Eur J Radiol2020
32943424Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.AJNR Am J Neuroradiol2020
32249755Analysis of the structure and factorial invariance of the Multidimensional Environmental Concern Scale (MECS).Psicothema2020
32210873Organic Learning Gardens in Higher Education: Do They Improve Kindergarten Pre-service Teachers' Connectedness to and Conception of Nature?Front Psychol2020
31486372PET or MRI to improve response evaluation in clinical trials?Lancet Oncol2019
31685588PET-CT for Evaluating Breast Cancer Yields Incidental Finding in the Lung.Radiol Technol2019
30119985Managing Nonmetastatic Castration-resistant Prostate Cancer.Eur Urol2019
31237493Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.Radiology2019
28906339Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features.Invest Radiol2018
29911685Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers.Eur Urol Oncol2018
30068710SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.Clin Cancer Res2018
29637509Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.J Neurooncol2018
29429804Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.Eur Urol2018
28753792Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey.Eur Urol Focus2018
27875103Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.Radiology2017
28450425Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.Cancer Discov2017
29262651High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy.Oncotarget2017
28571827Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital.Clin Genitourin Cancer2017
26807894Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.Radiology2016
27246360Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.Clin Genitourin Cancer2016
26965561Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.Eur Urol2016
25555314Progressive computed tomography (CT) appearances preceding malignant spinal cord compression (MSCC) in men with castration-resistant prostate cancer.Clin Radiol2015
28843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015
26510020DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.N Engl J Med2015
26065613Sequencing of agents in castration-resistant prostate cancer.Lancet Oncol2015
26085511Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.Clin Cancer Res2015
26000489Integrative clinical genomics of advanced prostate cancer.Cell2015
25454616PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.Eur Urol2015
25314055Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone.Br J Cancer2014
21044526Perception of personal identity at home.Psicothema2010
  • 1 - 49 of 49

Recommended Authors

Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Career Start Year 2018
Number of shared co-authors 1
Stephanie A Harmon
National Cancer Institute, National Institutes of Health
Career Start Year 2016
Number of shared co-authors 5
Anahita Fathi Kazerooni
University of Pennsylvania.
Career Start Year 2011
Number of shared co-authors 0
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 3
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 3
Brian P Hobbs
Dell Medical School, University of Texas at Austin
Career Start Year 2008
Number of shared co-authors 0
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 5
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 8
Arvind Rao
University of Michigan-Ann Arbor
Career Start Year 2006
Number of shared co-authors 8
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Guido Davidzon
Stanford University
Career Start Year 2005
Number of shared co-authors 0
Joost J C Verhoeff
University Medical Center Utrecht
Career Start Year 2005
Number of shared co-authors 0
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 7
Raymond Y Huang
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2002
Number of shared co-authors 0
Reid F Thompson
Oregon Health and Sciences University
Career Start Year 2002
Number of shared co-authors 2
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 5
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 8
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 19
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 7
Hugo J W L Aerts
Harvard Medical School
Career Start Year 1999
Number of shared co-authors 0
Andre Dekker
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 1
Amita Shukla-Dave
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 3
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 7
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Masoom A Haider
University Health Network
Career Start Year 1995
Number of shared co-authors 1
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 1
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 4
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 8

Collaborators

Johann S de Bono
The Institute for Cancer Research
Co-authored papers 25
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 23
Nina Tunariu
The Institute of Cancer Research
Co-authored papers 22
Zafeiris Zafeiriou
Theageneion Anticancer Hospital
Co-authored papers 13
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 10
Susana Miranda
The Institute of Cancer Research
Co-authored papers 10
Roberta Ferraldeschi
Astex Pharmaceuticals
Co-authored papers 9
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 8
Mark A Rubin
University of Bern
Co-authored papers 5
Penny Flohr
The Institute of Cancer Research
Co-authored papers 5
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Co-authored papers 5
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Wei Yuan
The Institute for Cancer Research
Co-authored papers 4
Adam Sharp
The Institute for Cancer Research
Co-authored papers 3
Gunther Boysen
Co-authored papers 3
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 3
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 3
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 3
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 3
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 3
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 3
Niven Mehra
Radboud university medical center
Co-authored papers 3
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 3
Matthew Clarke
Co-authored papers 3
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 3
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 3
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 3
Release 1.2